➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Harvard Business School
Johnson and Johnson
Dow
McKinsey

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

PHENAZINE-35 Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Phenazine-35 patents expire, and when can generic versions of Phenazine-35 launch?

Phenazine-35 is a drug marketed by Abc Holding and is included in one NDA.

The generic ingredient in PHENAZINE-35 is phendimetrazine tartrate. There are five drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.

US ANDA Litigation and Generic Entry Outlook for Phenazine-35

A generic version of PHENAZINE-35 was approved as phendimetrazine tartrate by VIRTUS PHARMS on December 31st, 1969.

  Start Trial

Summary for PHENAZINE-35
Drug patent expirations by year for PHENAZINE-35

US Patents and Regulatory Information for PHENAZINE-35

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abc Holding PHENAZINE-35 phendimetrazine tartrate TABLET;ORAL 085512-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Medtronic
Dow
Moodys
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.